(R)-1-Methylpyrrolidine-2-carboxylic acid hydrochloride, 95.0%, 25g

4-[3-(Thien-2-yl)-1,2,4-oxadiazol-5-yl]piperidine, 95.0%, 5g

6-Bromo-1H-indazol-4-amine, 95.0%, 1g

Methyl 2-(6-fluoropyridin-2-yl)acetate, 97%, 5g

4-(Oxazol-2-yl)aniline, 95.0%, 5g

3,4-Dimethoxybenzoic acid, 98.0%, 500g

N-(5-Guanidino-1-((4-nitrophenyl)amino)-1-oxopentan-2-yl)benzamide hydrochloride, 97.0%, 5g

4-sec-Butyl-2,6-di-tert-butylphenol>98.0%(GC)25g

[1-(Methylsulfonyl)cyclopropyl]methylamine hydrochloride, 95.0%, 100mg

6-Bromo-2,4-dimethylpyridin-3-amine, 97.0%, 5g

1,2-BENZENEDIAMINE, 4-(4-AMINOPHENOXY)-, 95%, 5g

tert-Butyl 2-oxo-5,6-dihydropyridine-1(2H)-carboxylate, 95.0%, 5g

anti-p16 Protein mouse monoclonal, DCS-50, 0.2 ml